Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
67%(2 trials)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
2
50%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)

Trials by Status

completed375%
active_not_recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruitingphase_1

Intravenous Estrogen in Kidney Transplant Study

NCT03663543
completednot_applicable

Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection

NCT04301934
completednot_applicable

The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides

NCT02524769
completedphase_4

Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients

NCT03032848

Clinical Trials (4)

Showing 4 of 4 trials
NCT03663543Phase 1

Intravenous Estrogen in Kidney Transplant Study

Active Not Recruiting
NCT04301934Not Applicable

Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection

Completed
NCT02524769Not Applicable

The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides

Completed
NCT03032848Phase 4

Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4